We are live on ! Find out more
Brian C. Broderick

Brian C. Broderick Portfolio holdings

AUM $660M Turnover 6.12%
1-Year Est. Return 39.39%
This Fund
S&P 500
This Quarter Est. Return
+3.14%
1 Year Est. Return
+39.39%
3 Year Est. Return
+113.87%
5 Year Est. Return
+133.67%
10 Year Est. Return
+411.02%
AUM
$286M
AUM Growth
+$5.92M
Cap. Flow
-$3.16M
Cap. Flow %
-1.1%
Top 10 Hldgs %
33.2%
Holding
86
New
7
Increased
16
Reduced
47
Closed
2
Avg Time Held
4.4 years
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
3.7 years

Top Buys

Rank Stock Value
1
ALC icon
Alcon
ALC
+$707K
2
KRSA icon
Korsana Biosciences
KRSA
+$466K
3
AMZN icon
Amazon
AMZN
+$443K
4
BDX icon
Becton Dickinson
BDX
+$352K
5
DOW icon
Dow
DOW
+$340K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$871K
2
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$716K
3
DD icon
DuPont de Nemours
DD
+$670K
4
MA icon
Mastercard
MA
+$504K
5
ORCL icon
Oracle
ORCL
+$372K

Sector Composition

Rank Sector Weight
1 Technology 23.06%
2 Healthcare 21.99%
3 Industrials 14.23%
4 Miscellaneous 12.78%
5 Financials 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MA icon
1
Mastercard
MA
$545B
$12.2M 4.28%
46,290
-2,012
-4% -$504K
2013 Q2
24 quarters
DHR icon
2
Danaher
DHR
$155B
$9.8M 3.44%
77,620
-238
-0.3% -$28.2K
2016 Q1
13 quarters
AAPL icon
3
Apple
AAPL
$4.98T
$9.5M 3.32%
191,888
-260
-0.1% -$12.7K
2013 Q2
24 quarters
CNI icon
4
Canadian National Railway
CNI
$73.4B
$9.46M 3.31%
102,303
-2,115
-2% -$194K
2013 Q2
24 quarters
JNJ icon
5
Johnson & Johnson
JNJ
$651B
$9.38M 3.28%
67,365
-2,080
-3% -$288K
2013 Q2
24 quarters
PG icon
6
Procter & Gamble
PG
$393B
$9.27M 3.24%
84,547
-2,301
-3% -$245K
2013 Q2
24 quarters
ATR icon
7
AptarGroup
ATR
$8.88B
$9.13M 3.19%
73,420
-1,172
-2% -$134K
2013 Q2
24 quarters
ADP icon
8
Automatic Data Processing
ADP
$119B
$8.39M 2.94%
50,755
-1,375
-3% -$223K
2013 Q2
24 quarters
ABT icon
9
Abbott
ABT
$178B
$8.16M 2.86%
97,041
-2,966
-3% -$233K
2013 Q2
24 quarters
ADI icon
10
Analog Devices
ADI
$168B
$7.99M 2.8%
70,818
-275
-0.4% -$29.8K
2016 Q2
12 quarters
NVS icon
11
Novartis
NVS
$284B
$7.99M 2.79%
87,465
-10,291
-11% -$871K
2013 Q2
24 quarters
GOOGL icon
12
Alphabet (Google) Class A
GOOGL
$3.26T
$7.89M 2.76%
145,660
+460
+0.3% +$26.6K
2015 Q3
15 quarters
XLNX
13
DELISTED
Xilinx
XLNX
$7.85M 2.75%
66,593
-891
-1% -$104K
2013 Q2
24 quarters
FISV icon
14
Fiserv
FISV
$29.7B
$7.33M 2.56%
80,417
-1,709
-2% -$150K
2013 Q2
24 quarters
MSFT icon
15
Microsoft
MSFT
$3.6T
$6.98M 2.44%
52,060
-558
-1% -$70.8K
2013 Q2
24 quarters
RTX icon
16
RTX
RTX
$257B
$6.92M 2.42%
84,454
+197
+0.2% +$16.5K
2013 Q2
24 quarters
MMM icon
17
3M
MMM
$91.8B
$6.76M 2.37%
46,643
-604
-1% -$93K
2013 Q2
24 quarters
CB icon
18
Chubb
CB
$142B
$6.62M 2.31%
44,922
-30
-0.1% -$4.33K
2015 Q3
15 quarters
HD icon
19
Home Depot
HD
$338B
$6.15M 2.15%
29,554
-448
-1% -$89.4K
2013 Q2
24 quarters
INTC icon
20
Intel
INTC
$273B
$6.06M 2.12%
126,520
-2,090
-2% -$104K
2013 Q2
24 quarters
ROK icon
21
Rockwell Automation
ROK
$39.7B
$5.66M 1.98%
34,565
+437
+1% +$73.8K
2013 Q2
24 quarters
UL icon
22
Unilever
UL
$137B
$5.05M 1.77%
72,476
+297
+0.4% +$20.2K
2015 Q2
16 quarters
ILMN icon
23
Illumina
ILMN
$29.2B
$4.87M 1.71%
13,611
+37
+0.3% +$11.7K
2014 Q2
20 quarters
XYL icon
24
Xylem
XYL
$21.7B
$4.84M 1.69%
57,920
+105
+0.2% +$8.37K
2014 Q2
20 quarters
PYPL icon
25
PayPal
PYPL
$44.3B
$4.27M 1.5%
37,337
+987
+3% +$109K
2017 Q4
6 quarters

Similar funds

Brian C. Broderick's Q2 2019 Portfolio in Review

As of Q2 2019, Brian C. Broderick held 86 positions worth $286M, up 2.1% from $280M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Brian C. Broderick's Q2 2019 filing shows 7 new, 16 increased, 47 reduced and 2 closed positions. Its largest new stake was Alcon: 12,049 shares worth $747K. The largest sale was Novartis, an estimated $871K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.

  • Brian C. Broderick's largest Q2 2019 buy was Alcon: 12,049 shares worth $747K.
  • Brian C. Broderick added most to Amazon in Q2 2019, an estimated $443K increase.
  • Brian C. Broderick's biggest Q2 2019 reduction was Novartis, cutting an estimated $871K.
  • Brian C. Broderick fully exited Altria Group in Q2 2019, selling an estimated $216K.
  • Brian C. Broderick's ten largest holdings make up 33% of its $286M portfolio in Q2 2019.
  • Brian C. Broderick opened 7 new positions and closed 2 in Q2 2019.
  • Brian C. Broderick's portfolio value rose 2.1% quarter-over-quarter to $286M.

Based on Brian C. Broderick's 13F filing for Q2 2019, filed 24 Jul 2019.